After Hours
$
0.99
Change
+0.0096 +0.98%
Volume
Volume 398
May 26, 2023, 7:13 p.m.
Quotes are delayed by 20 min
Previous close
$ 0.98
$ 0.98
Change
-0.0029 -0.29%
Day low
Day high
$0.98
$1.00

52 week low
52 week high
$0.82
$1.47

Market cap
$84.59M
Average volume
180,755
P/E ratio
N/A
Rev. per Employee
$333,333
EPS
-0.36
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on DARE
-
Daré Bioscience stock price target raised to $4 from $3 at Maxim Group
- Tomi Kilgore
-
Dare Biosciences rockets on Bayer licensing deal
- MarketWatch.com
-
Cerulean Pharma's stock plummets 64% premarket after jobs cuts and asset sales, stock purchase deal
- Tomi Kilgore
-
Cerulean Pharma downgraded to market perform from outperform at Leerink Partners
- Tomi Kilgore
-
Cerulean Pharma started at overweight with $8 stock price target at Barclays
- Tomi Kilgore
-
Almost half of venture-backed IPOs this year are losers
- Philip van Doorn
Analyst Ratings
-
- Benzinga.com
-
- Benzinga.com
Other News on DARE
-
- Edgar Online - (EDG = 10Q, 10K)
-
- Edgar Online - (EDG = 10Q, 10K)
-
Dare Bioscience, Inc. (DARE) Q3 2022 Earnings Call Transcript
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
- Edgar Online - (EDG = 10Q, 10K)
Press Releases on DARE
-
Dare Bioscience to Present at the 35th Annual Roth Conference
- GlobeNewswire
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com